An artificial intelligence accelerated virtual screening platform for drug discovery
Guangfeng Zhou, Domnița-Valeria Rusnac, Hahnbeom Park…·Frank DiMaio
The paper develops RosettaVS, an AI-accelerated virtual screening platform that identifies drug candidates with high binding affinity across two targets, achieving a 14% and 44% hit rate in under seven days.